Table 2.
Patient characteristics for nasopharyngeal swab samples
| Variable | SARS-CoV-2 negative (n = 12) |
SARS-CoV-2 positive (n = 54) |
P value |
|---|---|---|---|
| Age (years), mean (SD) | 57.63 (17.87) | 64.34 (13.68) | 0.241 |
| Sex: Male, n (%) | 4 (33.33) | 30 (55.56) | 0.283 |
| BMI, mean (SD) | 26.58 (7.49) | 29.57 (8.08) | 0.178 |
| Race: African American, n (%) | 3 (25) | 42 (77.78) | 0.001a |
| Current smoker: Yes, n (%) | 0 (0) | 7 (12.96) | 0.330a |
| Hospitalization, n (%) | 2 (16.67) | 54 (100) | <.001a |
| Ventilator, n (%) | 1 (8.33) | 16 (29.63) | 0.163a |
| Death due to COVID, n (%) | 0 (0) | 6 (11.11) | 0.582a |
| Chronic pulmonary disease: Yes, n (%)b | 1 (10) | 15 (31.91) | 0.253a |
| Congestive heart failure: Yes, n (%)b | 0 (0) | 12 (25.53) | 0.1a |
| Diabetes: Yes, n (%)b | 2 (20) | 29 (61.7) | 0.032a |
| Obesity: Yes, n (%)b | 2 (20) | 6 (12.77) | 0.619a |
| Hypertension: Yes, n (%)b | 4 (40) | 34 (72.34) | 0.069a |
Significance was evaluated on the basis of the Mann-Whitney U test and the chi-squared test or Fisher's exact test.
a
P value calculated using Fisher's exact test.
b
Two missing values in SARS-CoV-2-negative group and seven missing values in SARS-CoV-2-positive group.